{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:11:06Z","timestamp":1784772666296,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fortis Clinical Research Limited India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jchromb.2017.11.040","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T01:18:51Z","timestamp":1512177531000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI\u2013MS\/MS: Application in clinical study"],"prefix":"10.1016","volume":"1072","author":[{"given":"Kuldeep Kumar","family":"Namdev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Chandra","family":"Chilkoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2017.11.040_bib0005","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1080\/17512433.2016.1254041","article-title":"A pharmacological review of lamotrigine for the treatment of epilepsy","volume":"9","author":"Yasam","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0010","unstructured":"LAMICTAL \u00ae (lamotrigine) tablets prescribing information. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020241s037s038,020764s030s031lbl.pdf (Accessed: 20 September 2017)."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/clpt.1987.193","article-title":"Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans","volume":"42","author":"Cohen","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0883073897012001041","article-title":"Lamotrigine: pharmacokinetics","volume":"12","author":"Garnett","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","article-title":"In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction","volume":"34","author":"Rowland","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2147\/NDT.S1026","article-title":"Management of epilepsy in elderly","volume":"3","author":"Poza","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2125.1997.tb00028.x","article-title":"Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers","volume":"43","author":"Wootton","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FTD.0b013e318178e2a9","article-title":"Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium","volume":"30","author":"Franco","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0045","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0050","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1080\/17512433.2016.1254041","article-title":"A pharmacological overview of lamotrigine for the treatment of epilepsy","volume":"9","author":"Yasam","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.clinthera.2007.02.005","article-title":"Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy","volume":"29","author":"Makus","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0060","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1212\/01.wnl.0000313154.55518.25","article-title":"Clinical consequences of generic substitution of lamotrigine for patients with epilepsy","volume":"70","author":"LeLorier","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yebeh.2008.02.020","article-title":"Comparative daily profiles with different preparations of lamotrigine: a pilot investigation","volume":"13","author":"Nilsen","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0404.2007.00976.x","article-title":"Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product","volume":"117","author":"Sabroe","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1528-1167.2007.01007.x","article-title":"Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes","volume":"48","author":"Andermann","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0080","unstructured":"Epilepsy foundation- medication switching. Available at: https:\/\/www.epilepsy.com\/sites\/core\/files\/atoms\/files\/Medication%20Switching%20Position%20Statement.pdf (Accessed: 20 September 2017)."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4155\/bio.13.345","article-title":"How effective is the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring","volume":"6","author":"Baietto","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2125.2001.00394.x","article-title":"Therapeutic drug monitoring- antiepileptic drugs","volume":"52","author":"Eadie","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs \u2212best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0100","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.4155\/bio.11.220","article-title":"The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples","volume":"3","author":"O'Mara","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0378-4347(95)00170-0","article-title":"Simple and rapid analysis of lamotrigine, a novel antiepileptic, in human serum by high-performance liquid chromatography using a solid-phase extraction technique","volume":"670","author":"Yamashita","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00007691-199712000-00014","article-title":"High-performance liquid chromatography quantitation of plasma lamotrigine concentrations: application measuring trough concentrations in patients with epilepsy","volume":"19","author":"Sallustio","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007691-199702000-00020","article-title":"A rapid and specific assay for the determination of lamotrigine in human plasma by normal- phase HPLC","volume":"19","author":"Bartoli","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4347(96)00453-7","article-title":"New micromethod for the determination of lamotrigine in human plasma by high-performance liquid chromatography","volume":"691","author":"Londero","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00007691-199706000-00009","article-title":"Optimized high-performance liquid chromatographic method for determination of lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide","volume":"19","author":"Lensmeyer","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0731-7085(97)00234-3","article-title":"A rapid liquid chromatographic method for the determination of lamotrigine in plasma","volume":"17","author":"Matar","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-4347(99)00043-2","article-title":"Determination of lamotrigine in human plasma by high-performance liquid chromatography","volume":"727","author":"Angelis-Stoforidisa","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-4347(99)00459-4","article-title":"Determination of lamotrigine in human serum by liquid chromatography","volume":"736","author":"Vidal","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0378-4347(00)00102-X","article-title":"Validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma","volume":"741","author":"Barbosa","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00007691-200010000-00019","article-title":"Optimized procedure for lamotrigine analysis in serum by high-performance liquid chromatography without interferences from other frequently coadministered anticonvulsants","volume":"22","author":"Torra","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007691-200112000-00012","article-title":"New high-performance liquid chromatographic method for plasma\/serum analysis of lamotrigine","volume":"23","author":"Croci","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2005.09.009","article-title":"Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy","volume":"828","author":"Contin","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpba.2005.02.045","article-title":"Simultaneous determination of lamotrigine phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography","volume":"39","author":"Patil","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jchromb.2007.04.006","article-title":"Development of a simple column-switching high-performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD)","volume":"854","author":"Greiner","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0175","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1365\/s10337-010-1569-y","article-title":"A simple dried blood spot assay for therapeutic drug monitoring of lamotrigine","volume":"71","author":"AbuRuz","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2013.02.005","article-title":"A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots","volume":"923\u2013924","author":"Mohamed Shaha","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/cclm-2014-0472","article-title":"Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots","volume":"53","author":"Baldelli","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchromb.2007.06.023","article-title":"Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction","volume":"857","author":"Vermeij","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.microc.2016.09.007","article-title":"Determination of lamotrigine in human plasma and saliva using microextraction by packed sorbent and high performance liquid chromatography\u2013diode array detection: an innovative bioanalytical tool for therapeutic drug monitoring","volume":"130","author":"Ventura","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0021-9673(02)01257-8","article-title":"Therapeutic drug monitoring of lamotrigine using capillary electrophoresis: evaluation of assay performance and quality assurance over a 4-year period in the routine arena","volume":"979","author":"Theurillat","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0205","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0731-7085(90)80104-W","article-title":"Validation of a radioimmunoassay for the determination of human plasma concentrations of lamotrigine","volume":"8","author":"Biddlecombe","year":"1990","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-4347(97)00064-9","article-title":"Lamotrigine analysis in plasma by gas chromatography\u2013mass spectrometry after conversion to a tert. - butyldimethylsilyl derivative","volume":"693","author":"Dasgupta","year":"1997","journal-title":"J. Chromatogr B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0215","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/elps.200305823","article-title":"Development of capillary zone electrophoresis\u2013electrospray ionization-mass spectrometry for the determination of lamotrigine in human plasma","volume":"25","author":"Zheng","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.ftd.0000245779.64080.30","article-title":"Determination of lamotrigine and its metabolites in human plasma by liquid chromatography- mass spectrometry","volume":"28","author":"Beck","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4155\/bio.09.8","article-title":"Development of an ultra-performance liquid chromatography-tandem mass spectrometry micromethod for quantification of lamotrigine in human plasma and its use in a bioequivalence trial","volume":"1","author":"Marcel\u00edn-Jim\u00e9nez","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/chromsci\/48.5.375","article-title":"Rapid quantification of lamotrigine in human plasma by two LC systems connected with tandem MS","volume":"48","author":"Shah","year":"2010","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10072-010-0257-x","article-title":"Determination of lamotrigine in human serum by high-performance liquid chromatography- tandem mass spectrometry","volume":"31","author":"Lee","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bmc.1692","article-title":"Rapid and sensitive LC\u2013MS\/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study","volume":"26","author":"Hotha","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpha.2012.09.001","article-title":"Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: application to a pharmacokinetic study","volume":"3","author":"Ghatol","year":"2013","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.talanta.2013.02.010","article-title":"Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography\u2013electrospray ionization tandem mass spectrometry","volume":"110","author":"Kuhn","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FTD.0000000000000123","article-title":"Quantification of lamotrigine in patient plasma using a fast liquid chromatography-tandem mass spectrometry method with backflush technology","volume":"37","author":"Wong","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0260","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4155\/bio.15.99","article-title":"A LC\u2013MS\/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS","volume":"7","author":"Linder","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0265","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clinbiochem.2016.12.008","article-title":"Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: a step towards home sampling","volume":"50","author":"Linder","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0270","series-title":"FDA Guidance for Industry: Bioanalytical Method Validation","year":"2001"},{"key":"10.1016\/j.jchromb.2017.11.040_bib0275","first-page":"431","article-title":"Comparison of several regression procedures formethod comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II","volume":"22","author":"Passing","year":"1984","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0280","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpba.2016.08.002","article-title":"Development and validation of UHPLC-MS\/MS methods for the quantification of colistin in plasma and dried plasma spots","volume":"129","author":"Cangemi","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2017.11.040_bib0285","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217316707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217316707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T10:04:55Z","timestamp":1719655495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217316707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":57,"alternative-id":["S1570023217316707"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.11.040","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI\u2013MS\/MS: Application in clinical study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2017.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}